Neurology Minute

In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk.  Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving. 

In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder.  Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving. 

In part one of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss the term "functional seizures" and clarify the terminology.  Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving. 

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss small vessel primary CNS vasculitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397 

Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.14202   

In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.  

In the first episode of the AAN President's Spotlight series, Dr. Jason Crowell speaks with the new AAN President, Dr. Natalia S. Rost, as she outlines her vision and key priorities for her two-year term. Show references:  https://www.aan.com/about-the-aan/presidents-spotlight

In part two of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss how to approach the management of patients in clinic when there is concern for a possible false positive on the radioimmunoprecipitation assay for the acetylcholine receptor antibody. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498 

In part one of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss the clinical scenarios where the commonly used assay for myasthenia gravis is most likely to produce false positive results in patients who do not actually have myasthenia gravis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498  

Dr. Roy E. Strowd and Dr. Susannah Cornes discuss a teaching incentive initiative designed to support and reward faculty in academic neurology.  Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200182 

In the first installment of this three-part series, Dr. Elizabeth Zollos explores how optical coherence tomography is advancing our understanding of multiple sclerosis and enhancing diagnostic accuracy.   

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference: https://www.nature.com/articles/s41593-025-01910-9 

In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN.  Show reference:  https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award  

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference: https://www.nature.com/articles/s41593-025-01910-9 

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference:  https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award 

Dr. Jeff Lambe talks about progressive multiple sclerosis.  Show references: https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract  https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967  https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772  https://www.nejm.org/doi/full/10.1056/NEJMoa2415988   

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000210109  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract 

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.